Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Innoviva Inc (NQ: INVA )

11.43 USD -0.19 (-1.64%)
Official Closing Price Updated: 4:22 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 677,000
Open 11.66
Bid (Size) 11.26 (4)
Ask (Size) 13.00 (6)
Prev. Close 11.62
Today's Range 11.42 - 11.78
52wk Range 7.580 - 15.62
Shares Outstanding 101,470,190
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company's Bacteriophage Development Programs
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and... 
From PR Newswire
Innoviva Reports Fourth Quarter 2020 Financial Results
Innoviva, Inc. (NASDAQ: INVA) (the Company) today reported financial results for the fourth quarter ended December 31, 2020. 
From Business Wire News Releases

Performance

YTD
-8.41%
-8.41%
1 Month
-4.83%
-4.83%
3 Month
+9.33%
+9.33%
6 Month
-2.39%
-2.39%
1 Year
-17.05%
-17.05%

More News

Read More
A Look Into Healthcare Sector Value Stocks
Tags Dividends Market News Earnings
From Benzinga
Innoviva: Q4 Earnings Insights
Tags Earnings INVA Benzinga
From Benzinga
Innoviva Reports Third Quarter 2020 Financial Results
From Business Wire News Releases
Notable Insider Buys Seen In The Past Week: Green Brick, Intel, Teledyne And More
Tags TDY Green Brick Partners News
From Benzinga
First Week of September 17th Options Trading For Innoviva (INVA)
Tags Stocks
From Market News Video
5 Value Stocks To Watch In The Healthcare Sector
Tags Benzinga Dividends TNXP
From Benzinga
5 Value Stocks In The Healthcare Sector
Tags General INVA BZI/VS
From Benzinga
FDA Approves Trelegy Ellipta as the First Once-Daily Single Inhaler Triple Therapy for the Treatment of Both Asthma and COPD in the US
From Business Wire News Releases
First Week of INVA February 2021 Options Trading
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.